跳至主要内容
临床试验/ACTRN12618000303246
ACTRN12618000303246招募中4 期

Randomised controlled trial of paracetamol or ibuprofen, as required for fever and pain in the first year of life, for prevention of asthma at age six years: Paracetamol or Ibuprofen in the Primary Prevention of Asthma in Tamariki (PIPPA Tamariki).

Auckland District Health Board0 个研究点目标入组 3,922 人开始时间: 2018年2月28日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
3,922

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 8 Weeks(—)
性别
All

入选标准

  • 1. Birth within Auckland and Wellington regions.
  • 2. Age <8 weeks (chronological age).

排除标准

  • Infants will not be enrolled if ANY of the following apply:
  • 1. Parent is unable to give informed consent for participation in the trial;
  • 2. Highly unlikely to remain in New Zealand for the first 6 years of life;
  • 3. Chronic disease associated with limited life expectancy (i.e., less than 6 years);
  • 4. Gestational age at birth <32 weeks;
  • 5. Previous exposure to paracetamol or ibuprofen since birth.

研究者

相似试验